Pulmonx (LUNG) Profit After Tax (QoQ) (2019 - 2025)
Pulmonx (LUNG) Profit After Tax (QoQ) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Pulmonx | 50.56 Mn | -19.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 8.01% |
| Jun 30, 2025 | -5.67% |
| Mar 31, 2025 | -133.55% |
| Dec 31, 2024 | 7,528.88% |
| Sep 30, 2024 | 103.66% |
| Jun 30, 2024 | -11.47% |
| Mar 31, 2024 | -128.63% |
| Dec 31, 2023 | 422.02% |
| Sep 30, 2023 | 7.92% |
| Jun 30, 2023 | -2.11% |
| Mar 31, 2023 | 72.94% |
| Dec 31, 2022 | -314.72% |
| Sep 30, 2022 | 3.47% |
| Jun 30, 2022 | 7.51% |
| Mar 31, 2022 | 67.38% |
| Dec 31, 2021 | -74,746.15% |
| Sep 30, 2021 | 100.50% |
| Jun 30, 2021 | -3.60% |
| Mar 31, 2021 | -34.58% |
| Dec 31, 2020 | -142.93% |